Eli Lilly and Company News - May 26, 2026

Eli Lilly Price Target Lifted to $1,251 at BofA on Weight-Loss Drug Optimism
LLY

Eli Lilly Price Target Lifted to $1,251 at BofA on Weight-Loss Drug Optimism

BofA Securities raised its price target for Eli Lilly (LLY) to $1,251 from $1,133. The bank maintained its "Buy" rating on the stock. A positive outlook for...
Eli Lilly buys three biotechs for $4 billion, returning to vaccines
LLY

Eli Lilly buys three biotechs for $4 billion, returning to vaccines

Eli Lilly and Company will acquire Curevo Inc., LimmaTech Biologics, and Vaccine Company. The combined acquisitions total nearly $4 billion. This strategy...